8-K/A: Celsius Holdings Amends SEC Filing, Reveals Strong Financials for Acquired Alani Nutrition

Celsius Holdings, Inc. has filed an amendment to its recent 8-K, providing detailed audited financial statements for its newly acquired Alani Nutrition LLC, showcasing significant revenue and profit growth for the acquired entity in 2024.

Summary

• Celsius Holdings, Inc. filed an amendment (Form 8-K/A) to its April 1, 2025 Current Report on Form 8-K, primarily to include the audited consolidated financial statements of Alani Nutrition LLC (Alani Nu) and pro forma financial information.
• The amendment confirms the completion of Celsius's acquisition of Alani Nu on April 1, 2025.
• Alani Nu reported net sales of $605.38 million in 2024, a significant increase from $412.57 million in 2023, representing 46.7% growth.
• Gross profit for Alani Nu grew by 52.2% to $251.36 million in 2024, up from $165.14 million in 2023.
• Net income for Alani Nu increased by 53.6% to $64.04 million in 2024, compared to $41.70 million in 2023.
• Alani Nu's cash and cash equivalents rose sharply to $12.05 million in 2024 from $1.75 million in 2023.
• The company's members' equity transitioned from a deficit of $(1.40) million in 2023 to a positive equity of $25.71 million in 2024.
• The acquisition consideration included $1.275 billion in cash, 22,451,224 unregistered shares of Celsius common stock, and up to $25.0 million in additional cash consideration contingent on Alani Nu's 2025 net sales.
• Celsius financed a portion of the cash consideration with a new $900 million term loan facility.
• Pro forma combined revenue for Celsius and Alani Nu for the year ended December 31, 2024, would have been approximately $1.96 billion, with pro forma net income attributable to common stockholders of $80.21 million and basic/diluted EPS of $0.31.

Sentiment

Score: 8

Explanation: The document reveals strong financial performance for the acquired entity, Alani Nu, with significant growth in revenue, gross profit, and net income, and a positive shift in equity. The acquisition itself is strategic for Celsius, expanding its market presence. While there are standard risks associated with acquisitions and related party transactions, the overall financial health and growth trajectory of Alani Nu are highly positive.

Positives

• Alani Nu demonstrated robust financial growth, with net sales increasing by 46.7% to $605.38 million in 2024 from $412.57 million in 2023.
• Gross profit for Alani Nu significantly improved by 52.2% to $251.36 million in 2024, up from $165.14 million in 2023, indicating strong margin expansion.
• Alani Nu's net income surged by 53.6% to $64.04 million in 2024, compared to $41.70 million in 2023.
• Alani Nu's financial health improved substantially, moving from a members' equity deficit of $(1.40) million in 2023 to a positive equity of $25.71 million in 2024.
• Cash and cash equivalents for Alani Nu increased significantly to $12.05 million in 2024 from $1.75 million in 2023.
• The acquisition of Alani Nu, a high-growth brand, is expected to significantly boost Celsius's overall revenue, with pro forma combined revenue reaching approximately $1.96 billion for the year ended December 31, 2024.

Negatives

• Alani Nu reported a members' equity deficit of $(1.40) million as of December 31, 2023, before its significant improvement in 2024.
• Alani Nu incurred substantial distributions to members, totaling $71.96 million in 2023 and $36.93 million in 2024.
• Distributor termination expenses for Alani Nu increased from $4.87 million in 2023 to $10.69 million in 2024.
• Management services costs for Alani Nu significantly increased from $26.92 million in 2023 to $73.78 million in 2024.

Risks

• The pro forma financial information is based on preliminary estimates and assumptions, and the final acquisition accounting may differ materially, potentially impacting the recorded goodwill and amortization expenses.
• The pro forma statements do not reflect any anticipated synergies, operating efficiencies, cost savings, or integration costs that may arise from the acquisition.
• Alani Nu's cash balances at times exceeded insured limits, with approximately $11.45 million in excess of limits at December 31, 2024, posing a risk in case of financial institution failure.
• Concentration risk exists with major customers, as one customer comprised approximately 10% of accounts receivable and 11% of total revenues for Alani Nu in 2024.
• Concentration risk also exists with major vendors, as two vendors (one a related party) comprised approximately 28% of Alani Nu's vendor purchases in 2024.
• Alani Nu engages in significant related party transactions, including product sales, management services, and advances, which could present conflicts of interest or non-arm's length pricing.
• The Company's involvement with a Variable Interest Entity (VIE) through a related party, while not requiring consolidation, exposes it to potential losses if the VIE incurs excessive eligible costs for management services.
• The Company is involved in various claims and legal actions arising from the ordinary course of business, though management believes the ultimate disposition will not have a material adverse effect.

Future Outlook

The document indicates that the acquisition of Alani Nu was completed on April 1, 2025, and the pro forma financial information suggests a significant increase in Celsius's revenue base. An earnout payment of up to $25.0 million is contingent on Alani Nu's net sales meeting or exceeding an agreed target for calendar year 2025, indicating continued growth expectations for the acquired brand. The unregistered shares issued to sellers will be released from restrictions in tranches through April 2027.

Industry Context

The acquisition of Alani Nu by Celsius Holdings, Inc. signifies a strategic move to expand Celsius's product portfolio and market reach within the rapidly growing functional beverage and sports nutrition sectors. Alani Nu's strong growth rates (46.7% revenue increase in 2024) suggest a robust demand for its premium brand supplement and beverage products, aligning with broader industry trends favoring health-conscious consumer choices and diversified product offerings. This acquisition positions Celsius to capture a larger share of the market by integrating a complementary, high-performing brand.

Comparison to Industry Standards

• Alani Nu's financial performance, with a 46.7% increase in net sales and a 53.6% increase in net income from 2023 to 2024, demonstrates exceptional growth rates that likely significantly outperform the average growth of established companies in the broader beverage and supplement industries.
• For instance, while large, mature beverage companies might see low to mid-single-digit revenue growth, Alani Nu's figures are indicative of a high-growth, emerging brand.
• Specific comparable companies or projects are not detailed in the filing, but these growth metrics suggest Alani Nu was a highly attractive acquisition target, potentially exceeding the growth profiles of many direct competitors in the functional beverage space prior to its acquisition.

Legal Proceedings

• The Company is involved in various claims and legal actions arising from the ordinary course of business. Management believes the ultimate disposition of these matters will not have a material, adverse effect on the Company's financial position, results of operations, or liquidity.

Related Party Transactions

• Alani Nutrition LLC conducts business with a related party (through common ownership) that distributes its products in certain regions and internationally, with product sales to this related party totaling approximately $11.4 million in 2024 and $5.5 million in 2023.
• Accounts receivable due from this related party for product sales were approximately $3.1 million at December 31, 2024, and $2.0 million at December 31, 2023.
• Amounts receivable from this related party for certain advances due within twelve months were approximately $23.5 million at December 31, 2024.
• Alani Nutrition LLC terminated agreements with the related party distributor in certain locations in 2023, incurring approximately $4.9 million in distributor buyout expenses.
• A management services agreement exists with the related party in the United States, where the related party provides substantially all management services, including raw materials procurement and vendor/employee/lessor engagement.
• Total management services costs from the related party were approximately $76.0 million in 2024 and $28.0 million in 2023.
• Total procurement charges from the related party were approximately $59.0 million in 2024 and $44.0 million in 2023.
• Amounts due to the related party were approximately $0.7 million at December 31, 2024, and $4.8 million at December 31, 2023.
• Alani Nutrition LLC holds variable interests in this related party company and its subsidiaries, which is considered a Variable Interest Entity (VIE), but Alani Nutrition LLC is not deemed the primary beneficiary and thus does not consolidate it.

Stakeholder Impact

• Shareholders (Celsius): The acquisition of a high-growth company like Alani Nu is expected to enhance Celsius's market position and financial performance, potentially leading to increased shareholder value, though it also involves significant debt financing and share issuance.
• Shareholders (Alani Nu Sellers): Received substantial cash consideration and Celsius common stock, providing liquidity and a stake in the combined entity.
• Creditors (Celsius): The new $900 million term loan facility significantly increases Celsius's debt obligations.
• Employees (Alani Nu): Now part of a larger, publicly traded company, potentially offering new opportunities and integration challenges.
• Customers (Alani Nu): Expected to continue receiving products under Celsius's expanded distribution network.

Next Steps

• Final determination of the fair value of Alani Nu's acquired assets and assumed liabilities by Celsius.
• Celsius to complete a comprehensive review of Alani Nu's accounting policies to conform them to Celsius's policies.
• Potential earnout payment of up to $25.0 million to Alani Nu sellers if 2025 net sales targets are met.
• Release of unregistered Celsius common stock issued to sellers in tranches on April 1, 2026, October 1, 2026, and April 1, 2027.

Key Dates

Recommendation

Keywords

Celsius Holdings, Alani Nutrition, Acquisition, SEC Filing, 8-K/A, Financial Statements, Pro Forma, Beverage Industry, Sports Nutrition, Energy Drinks, Consumer Goods, Merger, Financial Performance, Revenue Growth, Net Income, Goodwill, Intangible Assets, Debt Financing